Compare Fortuna Mining Corp. Common Shares (FSM) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortuna Mining Corp. Common Shares vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Fortuna Mining Corp. Common Shares trades at $10.92 (market cap $3.13B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 4× Fortuna Mining Corp. Common Shares's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Fortuna Mining Corp. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fortuna Mining Corp. Common Shares for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FSM | HALO | |
|---|---|---|
Market Cap | $3.13B | $12.58B |
Volume | 6,504,680 | 2,179,278 |
Sector | Basic Materials | Health |
52-Week High | $13.66 | $115.22 |
52-Week Low | $7.84 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $2.75B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fortuna Mining Corp. Common Shares
Fortuna Mining is a Canadian precious-metals mining company with operations in Latin America and West Africa. It produces gold and silver and conducts exploration activities in several countries.
Read more on FSM →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
